A Pilot Study of ANXA2, MED12, CALM1 and MAPK1 Gene Variants in Primary Hyperparathyroidism
By:
References
- Khundmiri SJ, Murray RD, Lederer E. PTH and vitamin D. Compr Physiol 2016;6:561–601.size
- Fraser WD. Hyperparathyroidism. The Lancet 2009;374:145–58.
- Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol 2018;14:115–25.
- Gopinath P, Mihai R. Hyperparathyroidism. Surgery 2011;29:451–8.
- Mizamtsidi M, Nastos C, Mastorakos G, Dina R, Vassiliou I, Gazouli M, et al. Diagnosis, management, histology and genetics of sporadic primary hyperparathyroidism: Old knowledge with new tricks. Endocr Connect 2018;7:R56-68.
- Li Z, Yu L, Hu B, Chen L, Jv M, Wang L, et al. Advances in cancer treatment: a new therapeutic target, Annexin A2. J Cancer 2021;12:3587–96.
- Ciregia F, Cetani F, Pardi E, Soggiu A, Piras C, Zal-locco L, et al. Parathyroid Carcinoma and Adenoma Co-existing in One Patient: Case Report and Comparative Proteomic Analysis. Cancer Genomics Proteomics 2021;18:781–96.
- Giusti L, Cetani F, Ciregia F, Da Valle Y, Donadio E, Giannaccini G, et al. A proteomic approach to study parathyroid glands. Mol Biosyst 2011;7:687–99.
- Gonzalez C, Akula S, Burleson M. The role of media-tor subunit 12 in tumorigenesis and cancer therapeutics. Oncol Lett 2022;23:74.
- Lim WK, Ong CK, Tan J, Thike AA, Ng CCY, Rajasegaran V, et al. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Nat Genet 2014;46:877–80.
- Chai YJ, Chae H, Kim K, Lee H, Choi S, Lee KE, et al. Comparative gene expression profiles in parathyroid adenoma and normal parathyroid tissue. J Clin Med 2019;8.
- Bhattacharya S, Bunick CG, Chazin WJ. Target selectivity in EF-hand calcium binding proteins. Biochim Biophys Acta 2004;1742:69–79.
- Lu M, Berglund E, Larsson C, Höög A, Farnebo LO,. Bränström R. Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in human parathyroid adenoma. Journal of Endocrinology 2011;208:31–9.
- Guo Y, Pan W, Liu S, Shen Z, Xu Y, Hu L. ERK MAPK signalling pathway and tumorigenesis. Exp Ther Med 2020;19:1997–2007.
- Mahalingam CD, Datta T, Patil R V., Kreider J, Bonfil RD, Kirkwood KL, et al. Mitogen-activated protein <sup>27.</sup> kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone. Journal of Endocrinology 2011;211:145–56.
- Van Der Walt J. Pathology of the parathyroid glands. Diagnostic Histopathology 18(6): 2012.
- Viechtbauer W, Smits L, Kotz D, Budé L, Spigt M, Serroyen J, et al. A simple formula for the calculation of sample size in pilot studies. J Clin Epidemiol 2015;68:1375–9.
- Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome. variable. Stat Methods Med Res 2016;25:1057–73.
- Mazeh H, Sippel RS, Chen H. The role of gender in primary hyperparathyroidism: same disease, different presentation. Ann Surg Oncol. 2012;19:2958–62.
- Wang H, Shen Q, Ye L hua, Ye J. MED12 mutations in human diseases. Protein Cell 2013;4:643–6.
- Fairoozy RH, Cooper J, White J, Giambartolomei C, Folkersen L, Wannamethee SG, et al. Identifying low density lipoprotein cholesterol associated variants in the Annexin A2 (ANXA2) gene. Atherosclerosis 2017;261:60–8.
- Pereira-Martins DA, Coelho-Silva JL, Domingos IF, Weinhäuser I, Silveira DR, Cunha AF, et al. Association between ANXA2*5681 variant (rs7170178) and osteonecrosis in haemoglobin SS-genotyped patients. Br J Haematol2020;188:e8-11.
- Pandey S, Ranjan R, Pandey S, Mishra RM, Seth T, Saxena R. Effect of ANXA2 gene single nucleotide variant (SNP) on the development of osteonecrosis in Indian sickle cell patient: A PCR-RFLP approach. Indian J Exp Biol 2012;50:455–8.
- Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, et al. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat Biotechnol 2016;34:155–63.
- Mototani H, Mabuchi A, Saito S, Fujioka M, Iida A, Takatori Y, et al. A functional single nucleotide variant in the core promoter region of CALM1 is associated with hip osteoarthritis in Japanese. Hum Mol Genet 2005;14:1009–17.
- Yang H, Hu Z, Zhuang C, Liu R, Zhang Y. Association between the variants of CALM1 gene and osteoarthritis risk: A meta-analysis based on observational studies. Biosci Rep 2018;38.
- Shi J, Gao ST, Lv ZT, Sheng W Bin, Kang H. The association between rs12885713 variant in CALM1 and risk of osteoarthritis: A meta-analysis of case-control studies. Medicine 2018;97.
- Zhao D, Qiu GX, Wang YP, Zhang JG, Shen JX, Wu ZH, et al. Association of calmodulin1 gene variants with susceptibility to adolescent idiopathic scoliosis. Orthop Surg 2009;1:58–65.
- Zhao D, Qiu GX, Wang YP, Zhang JG, Shen JX, Wu ZH. Association between adolescent idiopathic scoliosis with double curve and variants of calmo-dulinl gene/estrogen receptor-a gene. Orthop Surg 2009;1:222–30.
- Cheva A, Chorti A, Boulogeorgou K, Chatzikyri-akidou A, Achilla C, Bontinis V, Bontinis A, Milias S, Zarampoukas T, Bakkar SY, Papavramidis T. Sporadic Parathyroid Adenoma: A Pilot Study of Novel Biomarkers in Females. Medicina (Kaunas). 2024;60:1100.
- Leon AC, Davis LL, Kraemer HC. The role and interpretation of pilot studies in clinical research. J Psychiatr Res. 2011;45:626-9.
- Kunselman AR. A brief overview of pilot studies and their sample size justification. Fertil Steril. 2024 Jun;121(6):899-901
- Brewer K, Costa-Guda J, Arnold A. Molecular genetic insights into sporadic primary hyperparathyroidism. Endocr Relat Cancer 2019;26:R53-72.
- Hunter D, De Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker R V., et al. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. Journal of Bone and Mineral Research 2001;16:371–8.
- Wang XM, Wu YW, Li ZJ, Zhao XH, Lv SM, Wang XH. Variants of CASR gene increase the risk of primary hyperparathyroidism. J Endocrinol Invest 2016;39:617–25.
- Soto-Pedre E, Newey PJ, Srinivasan S, Siddiqui MK, Palmer CNA, Leese GP. Identification of 4 New Loci Associated With Primary Hyperparathyroidism (PHPT) and a Polygenic Risk Score for PHPT. Journal of Clinical Endocrinology and Metabolism 2022;107:3302–8.
- Correa P, Lundgren E, Rastad J, Åkerström G, Westin G, Carling T. Multiple endocrine neoplasia type 1 variant D418D is associated with sporadic primary hyperparathyroidism. Surgery 2002;132:450–5.
- Chorti A, Achilla C, Tsalkatidou D, Moysidis M, Cheva A, Chatzikyriakidou A, et al. A Pilot Study of the Association VDR Variants With Primary Hyperparathyroidism. In Vivo 2023;37:1111–6.
- Colhoun HM, McKeigue PM, Smith GD. Problems of reporting genetic associations with complex outcomes. Lancet 2003;361:865–72.
- Munafò MR, Attwood AS, Flint J. Letter to the editor: Bias in genetic association studies: Effects of research location and resources. Psychol Med 2008;38:1213–4.
- Bias in Reporting of Genetic Association Studies. PLoS Med 2005;2:e419.
- Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genetics in Medicine 2002;4:46–61.
- Kraft P, Zeggini E, Ioannidis JPA. Replication in genome-wide association studies. Statistical Science 2009;24:561–73.
- Tam V, Patel N, Turcotte M, Bossé Y, Paré G, Meyre D. Benefits and limitations of genome-wide association studies. Nat Rev Genet2019;20:467–84.
- van Teijlingen E, Hundley V. The importance of pilot studies. Nurs Stand. 2002 Jun 19-25;16:33.
DOI: https://doi.org/10.2478/bjmg-2024-0011 | Journal eISSN: 2199-5761
Language: English
Page range: 33 - 39
Published on: Mar 6, 2025
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Related subjects:
© 2025 A Chorti, C Achilla, A Siasiaridis, I Aristeidis, A Cheva, Papavramidis T Theodosios, A Chatzikyriakidou, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.